Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

173.00

+2.12 (1.24%)

At close: Jul 20, 2026, 4:00 PM EDT

174.01

+1.01 (0.58%)

Pre-market: Jul 21, 2026, 6:04 AM EDT

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	17,395	14,197	13,568	13,005	11,526	8,083
Market Cap Growth	31.68%	4.64%	4.33%	12.83%	42.60%	-9.81%
Enterprise Value	16,542	13,132	12,947	12,402	10,800	7,812
Last Close Price	173.00	141.83	136.50	131.76	119.44	85.17
PE Ratio	26.61	30.37	41.49	53.34	76.56	92.58
Forward PE	17.09	15.87	18.15	21.34	22.53	24.55
PEG Ratio	0.36	0.75	0.31	0.65	0.66	1.12
PS Ratio	5.61	4.96	5.76	6.89	7.74	7.13
PB Ratio	5.11	4.36	5.24	5.83	6.75	5.88
P/TBV Ratio	5.21	4.47	5.47	6.06	7.07	6.07
P/FCF Ratio	20.93	18.96	24.35	35.96	35.70	34.67
P/OCF Ratio	20.14	18.14	22.79	33.35	33.96	31.51
EV/Sales Ratio	5.33	4.59	5.50	6.57	7.25	6.89
EV/EBITDA Ratio	19.96	20.23	21.67	45.56	40.81	68.89
EV/EBIT Ratio	20.71	21.21	22.69	49.43	43.37	76.21
EV/FCF Ratio	19.90	17.54	23.24	34.30	33.45	33.51
Debt / Equity Ratio	0.12	0.13	0.18	0.12	0.05	0.32
Debt / EBITDA Ratio	0.50	0.64	0.76	1.57	0.99	3.88
Debt / FCF Ratio	0.49	0.56	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.27	-0.33	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.11	-1.64	-1.04	-2.22	-2.74	-2.39
Net Debt / FCF Ratio	-1.09	-1.42	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.65	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.85	0.82	0.71	1.08	0.71	0.49
Quick Ratio	2.51	2.92	3.06	2.25	2.49	3.65
Current Ratio	2.93	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	20.08%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	11.80%	10.06%	11.50%	6.71%	8.10%	4.76%
Return on Invested Capital (ROIC)	24.02%	20.21%	22.27%	14.46%	17.26%	9.84%
Return on Capital Employed (ROCE)	19.82%	17.44%	19.65%	11.33%	13.62%	6.07%
Earnings Yield	3.84%	3.29%	2.41%	1.87%	1.31%	1.08%
FCF Yield	4.78%	5.27%	4.11%	2.78%	2.80%	2.88%
Buyback Yield / Dilution	0.68%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%
Total Shareholder Return	0.68%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

SEC Filings: 10-K · 10-Q